Journal profile · Respiratory System
Journal of Cystic Fibrosis
ISSN 1569-1993 · eISSN 1873-5010 · Elsevier · NETHERLANDS · Quarterly · Founded 2002
Journal of Cystic Fibrosis: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.01; hybrid open access; APC about USD 4,370; median 114 days to acceptance (96 articles, last 24 months); community-reported acceptance: fairly easy; 1,694 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Cystic Fibrosis is published by Elsevier and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research and Pediatric health and respiratory diseases, together about 60.5% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Cystic Fibrosis is the official journal of the European Cystic Fibrosis Society. The journal is devoted to promoting the research and treatment of cystic fibrosis. To this end the journal publishes original scientific articles, editorials, case reports, short communications and other information relevant to cystic fibrosis. The journal also publishes news and articles concerning the activities and policies of the ECFS as well as those of other societies related the ECFS.
From the journal's Aims & Scope
Research area (LetPub): Respiratory System
Editor-in-chief Carlos M FarinhaPublisher website
Editorial board by country: none in mainland China; most named United States 17, United Kingdom 6, France 6, Canada 3, Australia 3 (44 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cystic Fibrosis Research AdvancesMedicine46.4%
- Neonatal Respiratory Health ResearchMedicine8.3%
- Pediatric health and respiratory diseasesHealth Professions5.7%
- Inhalation and Respiratory Drug DeliveryMedicine4.8%
- Tracheal and airway disordersMedicine3.9%
- Child Nutrition and Feeding IssuesMedicine2.7%
- Bacterial biofilms and quorum sensingBiochemistry, Genetics and Molecular Biology2.6%
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine2.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Respiratory System | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Respiratory System | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.01LetPub ·
- Impact factor (publisher)
- 5.5Publisher website ·
- CiteScore 2026-06
- 10.2LetPub ·
- CiteScore (publisher)
- 10.2Publisher website ·
- SJR 2026-06
- 1.91LetPub ·
- SNIP 2026-06
- 1.59LetPub ·
- h-index
- 65LetPub ·
- h-index
- 117OpenAlex ·
- i10-index
- 2,081OpenAlex ·
- 2-year mean citedness
- 0.53OpenAlex ·
- Self-citation rate
- 16.4%LetPub ·
- Share of gold OA articles
- 31.33%LetPub ·
Volume
- Articles per year
- 159LetPub ·
Articles by year OpenAlex count · 19,275 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,595 | 72 | 65 |
| 2025 | 1,694 | 125 | 752 |
| 2024 | 1,719 | 1,678 | 1,817 |
| 2023 | 1,569 | 1,569 | 2,985 |
| 2022 | 1,303 | 1,303 | 3,725 |
| 2021 | 1,289 | 1,289 | 5,313 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
114 daysMedian, submission to acceptance · P25–P75 92 days – 156 days
- Acceptance to online
- median 9 days (96 articles)
- Submission to online
- median 126 days
- Sample
- 96 articles with submission and acceptance dates (396 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 27%Publisher website ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 48 daysPublisher website ·
- Submission to acceptance
- 117 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,370 / EUR 4,090 / GBP 3,500 / JPY 542,010 | — | — | |
| Publisher website | USD 4,510 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Cover letter
- Required
Article types accepted10, with length limits
- case reportThese must be carefully documented and must be of importance because they illustrate or describe unusual features or have important therapeutic implications. Ca…main text ≤ 1,200 words · references ≤ 5
- editorialand 1 table or figure may be included. Editorials These are invited papers of around 1,000 words. There are no abstract, keywords or section headings. Casemain text ≤ 1,000 words
- editorialsEditorials These are invited papers of around 1,000 words. There are no abstract, keywords or section headings.Length not stated
- letterThese are short articles relating to papers recently published in the Journal or introducing an “Hot Topic” and they should come from authors who have published…main text ≤ 800 words · references ≤ 10
- original articlecieties related the ECFS. Article types Original articles Original research papers should contain no more than 3,000 words for the manuscript body (excluding ti…main text ≤ 3,000 words · figures and tables ≤ 5 · references ≤ 30
- original articlesOriginal articles Original research papers should contain no more than 3,000 words for the manuscript body (excluding title page, abstract and references) plus …Length not stated
- reviewhould be authoritative, well-referenced reviews of a relevant subject and should not contain more than 5,000 words for the manuscript body and 50 references wit…main text ≤ 5,000 words
- review articleReview papers should be authoritative, well-referenced reviews of a relevant subject and should not contain more than 5,000 words for the manuscript body and 50…main text ≤ 5,000 words · figures and tables ≤ 6 · references ≤ 50
- short communicationffice before submitting the manuscript. Short Communications 1,200 words for manuscript body plus no more than 3 figures or tables imain text ≤ 1,200 words · figures and tables ≤ 3 · references ≤ 20
- short communicationsShort Communications 1,200 words for manuscript body plus no more than 3 figures or tables in total and 20 references. These should contain brief reports of unu…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Single corresponding author required; primary contact during editorial process. Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Authors must follow Elsevier's Publishing Ethics Policy. Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized peer review; minimum two reviewers; editors make final decision. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Quarterly
- Founded
- 2002
- ISSN
- 1569-1993
- Electronic ISSN
- 1873-5010
- Society / sponsor
- European Cystic Fibrosis Society
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Cystic Fibrosis
What CAS zone is Journal of Cystic Fibrosis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Cystic Fibrosis is in Zone 2 of Medicine, and in Zone 2 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Cystic Fibrosis?
The latest impact factor listed by LetPub is 5.01; CiteScore 10.2, h-index 117.
How long does peer review take at Journal of Cystic Fibrosis?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 114 days (interquartile range 92–156 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 27%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Cystic Fibrosis?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Cystic Fibrosis based?
Of the 44 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (17), United Kingdom (6) and France (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Cystic Fibrosis?
According to LetPub and DOAJ records, Journal of Cystic Fibrosis is indexed in SCIE and Scopus.
Is Journal of Cystic Fibrosis open access, and what is the APC?
Journal of Cystic Fibrosis is a hybrid journal. For open-access publication: APC about USD 4,370.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .